Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timothy syndrome and CACNA1C-Related Disorder: first international language and management guidelines consensus statement.

European journal of human genetics : EJHG·2026
Same author

Ageism is not just about age: Introducing the concept of generalized discrimination experiences.

Developmental psychology·2026
Same author

CA in AF With LVSD With and Without LV Fibrosis: Results From the CAMERA-MRI II Trial.

JACC. Clinical electrophysiology·2026
Same author

Local Anesthesia and Analgosedation for Surgical Micro-Axial Flow Pump Implantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Effects of cardiac resynchronization therapy in adults with congenital heart disease.

BMC cardiovascular disorders·2026
Same author

Perioperative high-dose selenium supplementation in open thoracic aortic surgery: a post hoc subgroup analysis of the SUSTAIN CSX trial.

Journal of thoracic disease·2026

Related Experiment Video

Updated: May 13, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Current genomics in cardiovascular medicine.

Vinit Sawhney1, Scott Brouilette, Dominic Abrams

  • 1Department of Cardiology, St Bartholomew's Hospital, London, U.K ; William Harvey Research Institute, Queen Mary University London, U.K.

Current Genomics
|March 2, 2013
PubMed
Summary

Genomic studies are revolutionizing cardiovascular medicine by identifying genetic predispositions to cardiovascular disease (CVD). This research paves the way for novel therapeutics and personalized medicine approaches.

Keywords:
Cardiovascular diseaseGWASGene sequencingPersonalised medicine.

More Related Videos

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart
06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Experiment Videos

Last Updated: May 13, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart
06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Area of Science:

  • Genetics and Genomics
  • Cardiovascular Medicine
  • Human Disease

Background:

  • Cardiovascular disease (CVD) is a complex, heterogeneous condition significantly contributing to global morbidity and mortality.
  • Both common genetic variations and rare genetic disorders offer insights into CVD pathogenesis.
  • The genomic era, enabled by the Human Genome Project, has introduced advanced tools for genetic research in cardiovascular medicine.

Purpose of the Study:

  • To review the rationale behind large-scale genomic studies in cardiovascular medicine.
  • To elaborate on the methodologies of genome-wide association studies (GWAS).
  • To summarize the impact of genomics on clinical cardiovascular medicine and future therapeutic strategies.

Main Methods:

  • Review of current literature on cardiovascular genetics and genomics.
  • Discussion of genome-wide association studies (GWAS) as a key methodology.
  • Synthesis of findings on the clinical impact of genomic research.

Main Results:

  • Genomic approaches are crucial for understanding the complex genetic basis of CVD.
  • Genome-wide association studies (GWAS) have identified numerous genetic loci associated with CVD risk.
  • Genomics is transforming clinical practice, offering potential for new treatments and personalized medicine.

Conclusions:

  • Large-scale genomic studies are essential for unraveling the genetic architecture of cardiovascular disease.
  • The integration of genomics into clinical cardiovascular medicine promises to advance diagnostics and therapeutics.
  • Future directions include leveraging genomic insights for personalized medicine and the development of novel CVD treatments.